Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-23

FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Epic Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for Bupropion hydrochloride extended-release (XL), manufactured by Epic Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)